Pre-Course Offerings

Review Course Pre-Courses Header

Expand Your Clinical Knowledge

Take advantage of two valuable courses, that will qualify you for a DEA waiver for prescribing buprenorphine for the treatment of opioid dependence and educate you on the safe prescribing ER/LA Opioids. These courses are held in advance of the ASAM Review Course on Wednesday, July 29, 2015.


  1. Attendance at the Review Course is not required in order to take these two offerings.
  2. Review Course attendees do not need to attend these courses as part of the ABAM Certification Examination preparation.

The ASAM Buprenorphine Course for Office-Based Treatment of Opioid Use Disorders 

Wednesday, July 29, 2015
12:30 pm - 4:45 pm 

ASAM offers this 8 hour course in a blended format combining online and live learning to meet the needs of today’s busy physicians. The first half of the course is administered online through 4 hours of independent self-paced learning followed by a competency exam which must be successfully completed as part of the process to obtain a waiver for prescribing buprenorphine. The second half of the course is delivered by recognized national experts in a 4 hour interactive and engaging face to face classroom setting. 

The CO*RE/ASAM ER/LA Opioid REMS: Achieving Safe Use While Improving Patient Care Course - Free!

Wednesday, July 29, 2015
5:45 pm - 9:00 pm
Nationwide Via LIVE Webinar

The ER/LA Opioid REMS course was developed by nationally known experts in the ER/LA opioid field. ASAM’s REMS course is CO*RE-branded material, but will also include a special focus on addiction medicine. Participants, both live and remote, must complete the course assessment and evaluation in order to claim credit.

Questions? Contact ASAM’s Education Department

American Society of Addiction Medicine
4601 North Park Avenue
Upper Arcade, Suite 101
Chevy Chase, MD 20815-4520
Education Department
Phone: 301-656-3920 | Fax: 301-656-3815 | Email: | Web: